Clinical Trial

Relationship Between Selected Parameters and Bruxism

Study acronym: WMU1/2019
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Bruxism is a common phenomenon. It is estimated that its prevalence in the adult population is 8-31%. Bruxism occurring during sleep is the activity of the masticatory muscles that appear during sleep, which can be rhythmic or phased and is not a movement disorder or sleep disorder in healthy people. It is currently believed that bruxism should not be considered a disorder. In healthy people, it is treated rather as behavior, which may be a risk factor for pathological clinical implications or a protective factor in the presence of other disease entities. The most common symptoms of bruxism include: pathological wear and tooth sensitivity, periodontal and oral mucosa damage, myalgia in the stomatognathic system, headache and prosthetic restoration damage. However, due to nocturnal occurrence, bruxism symptoms may go unnoticed for a long time, which means that patients are often unaware of this behavior. The etiology of bruxism is multifactorial and not fully understood. It is currently believed that it can be caused by genetic, psychological and exogenous factors. Due to the unclear etiology of bruxism, it is so important to conduct research that allows making a certain diagnosis and finding the causes of this phenomenon
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-05 -> 2026-12 2026-07-10
Trial Details
NCT Number NCT04214561
Lead Sponsor Wroclaw Medical University
Conditions Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain, Anxiety, Mental Status Change, Temporomandibular Disorder
Enrollment 50 participants
Start Date 2019-12-16
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-09